Chun-jun Li
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Gout, Hyperuricemia, Uric Acid
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 13
- Diabetes Treatment and Management 12
- Nephrology 13
- Chronic Kidney Disease and Diabetes 7
- Gout, Hyperuricemia, Uric Acid 5
- Co-authors
- Demin M. Yu (20 shared papers)Liming Chen (13 shared papers)Lin Lv (7 shared papers)Ming‐Lin Liu (4 shared papers)Bei Sun (13 shared papers)Qiu-Mei Zhang (10 shared papers)Pei Yu (10 shared papers)Hui Li (1 shared paper)
- Journals
- Diabetology & Metabolic Syndrome (6 papers)Diabetes Metabolic Syndrome and Obesity (5 papers)Cardiovascular Diabetology (3 papers)Frontiers in Pharmacology (3 papers)Frontiers in Endocrinology (3 papers)
- Partner nations
- ChinaUnited StatesSweden
In The Last Decade
Chun-jun Li
99 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 93
- Nephrology 274
- Cancer Research 288
- Endocrinology, Diabetes and Metabolism 354
- Complementary and alternative medicine 108
- Cardiology and Cardiovascular Medicine 246
Countries citing papers authored by Chun-jun Li
This map shows the geographic impact of Chun-jun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun-jun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun-jun Li more than expected).
Fields of papers citing papers by Chun-jun Li
This network shows the impact of papers produced by Chun-jun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun-jun Li. The network helps show where Chun-jun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Chun-jun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 160 | |
| 2 | 2014 | 128 | |
| 3 | 2017 | 115 | |
| 4 | 2013 | 110 | |
| 5 | 2020 | 105 | |
| 6 | 2020 | 92 | |
| 7 | 2014 | 76 | |
| 8 | 2016 | 72 | |
| 9 | 2016 | 66 | |
| 10 | 2021 | 65 | |
| 11 | 2015 | 60 | |
| 12 | 2012 | 58 | |
| 13 | Attenuation of myocardial apoptosis by alpha-lipoic acid through suppression of mitochondrial oxidative stress to reduce diabetic cardiomyopathy. | 2009 | 51 |
| 14 | 2019 | 47 | |
| 15 | 2014 | 46 | |
| 16 | 2017 | 46 | |
| 17 | 2014 | 43 | |
| 18 | 2016 | 37 | |
| 19 | 2020 | 36 | |
| 20 | 2014 | 33 |
About Chun-jun Li
Chun-jun Li is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Epidemiology, Cancer Research and Physiology, having authored 103 papers that have together received 2.2k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (13 papers), Diabetes Treatment and Management (12 papers), Liver Disease Diagnosis and Treatment (9 papers), Chronic Kidney Disease and Diabetes (7 papers), Sleep and related disorders (5 papers), Gout, Hyperuricemia, Uric Acid (5 papers), Adipokines, Inflammation, and Metabolic Diseases (5 papers) and Body Composition Measurement Techniques (5 papers). The work is most often cited by research in Nephrology (274 citations), Cancer Research (288 citations), Endocrinology, Diabetes and Metabolism (354 citations), Complementary and alternative medicine (108 citations) and Cardiology and Cardiovascular Medicine (246 citations). Chun-jun Li has collaborated with scholars based in China, United States and Sweden. Frequent co-authors include Demin M. Yu, Liming Chen, Lin Lv, Ming‐Lin Liu, Bei Sun, Qiu-Mei Zhang, Pei Yu, Hui Li, Qianhua Fang and Jing‐Na Lin. Their work appears in journals such as Diabetology & Metabolic Syndrome, Diabetes Metabolic Syndrome and Obesity, Cardiovascular Diabetology, Frontiers in Pharmacology and Frontiers in Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.